Lesions of the Inferior Olive in Cases of Autoimmune GFAP Astrocytopathy: A Case Series Report - Report - MDSpire

Lesions of the Inferior Olive in Cases of Autoimmune GFAP Astrocytopathy: A Case Series Report

  • By

  • Haruka Kuwashige

  • Atsuhiko Sugiyama

  • Shinji Aoyama

  • Hideo Handa

  • Mitsuyoshi Tamura

  • Hiroki Masuda

  • Yuki Nakagawa

  • Masahiro Namiki

  • Hajime Yokota

  • Hiroki Mukai

  • Akio Kimura

  • Takayoshi Shimohata

  • Masahiro Mori

  • January 31, 2026

  • 0 min

Share

Clinical Report: Lesions of the Inferior Olive in Autoimmune GFAP Astrocytopathy

Overview

This report presents two cases of autoimmune GFAP astrocytopathy with lesions in the inferior olive, highlighting the clinical and imaging features associated with this condition. The findings underscore the importance of recognizing these lesions for accurate diagnosis and management.

Background

Autoimmune GFAP astrocytopathy is an inflammatory disorder characterized by IgG autoantibodies against GFAP, leading to a spectrum of neurological symptoms including meningoencephalitis and myelitis. The condition poses diagnostic challenges due to its clinical heterogeneity and the need for specific imaging features for early detection. Understanding the implications of lesions in the inferior olive can enhance diagnostic accuracy and treatment strategies.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

  • Two cases of autoimmune GFAP astrocytopathy with lesions in the inferior olive were documented.
  • Characteristic imaging features include bilateral hyperintense lesions in the inferior olive on T2-weighted MRI.
  • Clinical symptoms included tremors, disorientation, and autonomic dysfunction.
  • CSF analysis showed elevated white blood cell counts and protein levels, indicative of inflammation.
  • High-dose corticosteroid therapy is a common treatment approach for autoimmune GFAP astrocytopathy.

Clinical Implications

Recognition of inferior olive lesions in patients with autoimmune GFAP astrocytopathy can aid in the differential diagnosis and prompt appropriate treatment. Clinicians should consider high-dose corticosteroids as a first-line therapy, particularly in cases with severe symptoms or significant imaging findings.

Conclusion

The presence of lesions in the inferior olive in autoimmune GFAP astrocytopathy highlights the need for heightened awareness among clinicians. Early diagnosis and treatment can significantly impact patient outcomes.

Related Resources & Content

  1. conexiant, Conexiant, 2023 -- Steroid Pulse Therapy Benefits GFAP Astrocytopathy
  2. Acta Neuropathologica, Acta Neuropathologica, 2023 -- Recent Advances in Understanding the Neuropathology and Mechanisms of Autoimmune GFAP Meningoencephalomyelitis
  3. Acta Neuropathologica, Acta Neuropathologica, 2020 -- Pathological Insights into Inflammatory Demyelinating Disorders of the Central Nervous System Associated with Myelin Oligodendrocyte Glycoprotein Autoantibodies
  4. Frontiers, Frontiers, 2024 -- Review of clinical and imaging findings in autoimmune glial fibrillary acidic protein astrocytopathy to aid in early diagnosis
  5. PMC, PMC, 2023 -- Inferior olive lesions in autoimmune glial fibrillary acidic protein astrocytopathy: a report of two cases
  6. Acta Neuropathologica — Antibody Profiles in Patients with Histologically Characterized Patterns of Multiple Sclerosis
  7. Frontiers | Review of clinical and imaging findings in autoimmune glial fibrillary acidic protein astrocytopathy to aid in early diagnosis
  8. The Treatment of Antibody-Mediated Encephalitis: Current, Future Therapies, Unmet Need and Patient Management | Advances in Therapy | Springer Nature Link
  9. Inferior olive lesions in autoimmune glial fibrillary acidic protein astrocytopathy: a report of two cases - PMC

Original Source(s)

Related Content